Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2019
Hard copies of the report may be ordered free of charge by sending requests to:
Taro Pharmaceuticals U.S.A., Inc.
3 Skyline Drive
Hawthorne, NY 10532
attention: William J. Coote or
via email to William.Coote@Taro.com
Additionally, the report may be accessed on the SEC’s website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190621005263/en/
Contacts
Mariano A. Balaguer
VP, CFO
(914) 345-9001
Mariano.Balaguer@taro.com
William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com
Source: Taro Pharmaceutical Industries Ltd.